A Novel Human Cellular System for Studying Normal Aging and for Anti-Aging Discovery

Area of Science:

• Cellular and Molecular Biology
• Gerontology
• Reproductive Biology

Background:

• Animal and cellular models are crucial for aging research but have limitations in human applicability.
• Translating aging discoveries from non-human models to human contexts remains a significant challenge.

Purpose of the Study:

• To establish a novel human normal cell aging model using placental cells.
• To validate this model's recapitulation of key human aging features.
• To enable scalable screening of anti-aging interventions.

Main Methods:

• Development of an in vitro human trophoblast stem cell (hTSC) to syncytiotrophoblast (STB) differentiation system.
• Characterization of STB aging features including multinucleation, cell cycle arrest, and senescence-associated secretory phenotypes (SASPs).
• Utilizing a CGA-EGFP reporter hTSC line for quantitative screening of anti-aging compounds.

Main Results:

• The hTSC-STB system accurately recapitulates in vivo cytotrophoblast (CTB) to STB maturation and aging.
• Progressive senescence in STBs mirrors aging trajectories in other human stem cells.
• Tested anti-aging molecules (mTOR inhibitors, senolytics) effectively reduced senescence signals.
• The reporter system facilitated identification of potential anti-aging candidates.

Conclusions:

• The hTSC-STB system provides a physiologically relevant, accelerated human cellular aging model.
• This model bridges fundamental aging research and clinical intervention development.
• It offers a platform for prioritizing and validating anti-aging candidates for human application.